Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
Clinical trial NCT00171951 · COMPLETED
Trial details
- NCT number
- NCT00171951
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-13
- Primary completion
- 2013-07-08
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.